Patient well-being symposium aims to raise awareness and offer solutions Day 4 from Amsterdam 2023 / By Niall Slowey
Delving into the distribution of retinal biomarkers for insights on disease aetiology and clinical features Day 4 from Amsterdam 2023 / By Niall Slowey
Session on age-related macular degeneration (AMD) covers topics relating to risk factor identification and treatment Day 4 from Amsterdam 2023 / By Niall Slowey
Speakers’ corner proving big hit with attendees Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
RETINAWS: When the going gets tough, the tough get going Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
Free Paper Winner: PULSAR trial shows efficacy of aflibercept 8 mg in wet AMD Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
Specialists delve deep to unravel retinal mysteries Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
EVER Symposium: Defusing the ticking timebomb of high myopia Day 4 from Amsterdam 2023, Latest News / By Niall Slowey
